NASS 2018 Annual Meeting

Howard An, MD




Royalties: U&I (C), Zimmer Spine (B); Stock Ownership: U&I (<1%), Spinal Kinetics (<1%), Medyssey (<1%); Consulting: Bioventus (B); Board of Directors: Articular Engineering (21%); Scientific Advisory Board: Spinal Kinetics (<1%); Endowments: Rush University Medical Center (D, Paid directly to institution/employer); Research Support - Staff and/or Materials: Yuhan (E, Paid directly to institution/employer); Grants: SpinalCyte (F, Paid directly to institution/employer); Fellowship Support: AOSpine (E, Paid directly to institution/employer).

Sessions :